BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Nektar Therapeutics To Announce Financial Results For The Third Quarter 2015 On Thursday, November 5, 2015, After Close Of U.S.-Based Financial Markets

  October 30, 2015

   · 

  3 min read
• Lone Star Bio

  National MS Society Conference Serves As Platform To Share Newest Advances In MS Research & Treatment Attracting More Than 800 Leaders In The MS Movement

  October 30, 2015

   · 

  5 min read
• Business

  Q BioMed Inc. And Mannin Research Inc Sign Definitive License Agreement

  October 30, 2015

   · 

  6 min read
• FDA

  Regeneron Announces EU Approval Of EYLEA (Aflibercept) Injection For The Treatment Of Visual Impairment Secondary To Myopic Choroidal Neovascularization

  October 30, 2015

   · 

  8 min read
• Business

  FAU And Max Planck Institute Sign Innovative Agreement To Recruit And Retain Promising Scientists

  October 30, 2015

   · 

  6 min read
• Biotech Bay

  XenoPort To Present At The Credit Suisse Healthcare Conference

  October 30, 2015

   · 

  1 min read
• Business

  AtriCure Announces Upcoming Investor Conference Schedule

  October 30, 2015

   · 

  1 min read
• Business

  PerkinElmer Board Declares Quarterly Dividend

  October 30, 2015

   · 

  1 min read
• Drug Development

  Portola Completes Enrollment In Pivotal Phase III APEX Study Of Betrixaban For Prevention Of Blood Clots In Acute Medically Ill Patients

  October 30, 2015

   · 

  6 min read
• Business

  CASMED To Report Third Quarter 2015 Financial Results And Hold Conference Call On November 5

  October 30, 2015

   · 

  1 min read